Stock ONCO ONCOPEPTIDES AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Oncopeptides AB

Equities

ONCO

SE0009414576

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-06-28 EDT 		5-day change 1st Jan Change
2.93 SEK +5.40% Intraday chart for Oncopeptides AB +1.38% -61.75%
06-27 Transcript : Oncopeptides AB - Special Call
05-30 Oncopeptides Issues Warrants Under Loan Deal with European Investment Bank MT

Evolution of the average Target Price on Oncopeptides AB

Price target over the last 5 years

History of analyst recommendation changes

493e87.xcKtTLsky_BP0XRxsKmkmO-oZvm5zSA_O4Tpgnn1J0k.rZbhGOl8osY5vg4Yx__u1aruF63DlGF4f-eT8k27diOLpcgvz3TmtRW2MQ~6a1eb76473a9ade2d6ba7f8ffe70d4a5

Analyst Recommendations on Oncopeptides AB

Oncopeptides Issues Warrants Under Loan Deal with European Investment Bank MT
Oncopeptides Announces 26% Overall Response Rate of Melflufen in Triple-Class Refractory Multiple Myeloma Patients from the Pivotal HORIZON Study CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.93 SEK
Average target price
6.1 SEK
Spread / Average Target
+108.19%
High Price Target
6.8 SEK
Spread / Highest target
+132.08%
Low Price Target
5.5 SEK
Spread / Lowest Target
+87.71%

Consensus detail

Consensus revision (last 18 months)

Ratings for Oncopeptides AB

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ONCO Stock
  4. Consensus Oncopeptides AB